ResMed (RMD) Reports In-Line Q4 EPS, Revenues Slightly Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2018
August 2, 2018 4:05 PM EDTRevenue increased 12% to $623.6 million; up 10% on a constant currency basis Net income increased by 8%; non-GAAP net income up 24% GAAP diluted earnings per share of $0.76; non-GAAP diluted earnings per share of $0.95 Operating cash flow of $129.4 million in the fourth quarter Quarterly dividend increased by 6% to $0.37 per share
SAN DIEGO--(BUSINESS WIRE)-- ResMed Inc. (NYSE: RMD) (ASX: RMD) today announced results for... More
